NanoLight.com
Title
Luciferase Luciferin Fluorescent Protein Coelenterazine
Description
NanoLight Technologies is a division of Prolume Ltd., a biotechnology company developing broad applications of natural, light-emitting marine proteins, or marine bioluminescence. The NanoLight division is focused on becoming the leader in high-value reagent & reporter systems for new product development in the pharmaceutical, agrichemical, and research products industries.
Valuable life science uses for NanoLight’s technology include high-throughput drug discovery, functional genomics, tumor imaging, replacement of radioisotopes, and molecular diagnostics. One particularly exciting application is the ability to use NanoLight’s reporter systems to “illuminate” gene and molecular function within living cells, allowing pharmaceutical companies a revolutionary method to study drug activity. A second opportunity is to broadly supply researchers who are increasingly moving away from radioactive reagents and toward light-based reporter systems and instruments. NanoLight Technologies is poised to capitalize on both of these accelerating market trends.
These proprietary technologies, which NanoLight has already developed or protected by patent filings & trade secrets, permit the company to grow into the dominant supplier of proprietary bioluminescent reagent and reporter systems to the life science markets. NanoLight can immediately provide partners access to:
Additional Information
Related Domains
- Aequorin
- Apoaequorin
- Bioluminescent
- Bioluminescent Reagent
- Biomedical Engineering
- Calcium Channel Indicator
- Coelenterazine
- Copepod
- Cypridina
- Drug Screening
- Gfp
- Glowing
- Green Fluorescent Protein
- High Throughput Screening
- Luciferase
- Obelin
- Phlourin
- Ptilosarcus
- Renilla Muelleri
- Renilla Mullerei
- Renilla Reniformis
- Reporter
- Science
- Sea Pansy
- Sea Pen
- Substrate
- Technology
- Vargula
- GFP